BioNexus Gene Lab Corp
BGLC · Services Medical Laboratories
Latest available SEC filing: SCHEDULE 13D ·
Latest disclosures
-
Tan Lee Su-Leng: Form 4
Insider disclosure · Filed · Report period 13 Aug 2026
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13D
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001737523 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- BGLC on Nasdaq
- SEC industry group
- Services Medical Laboratories (Industrial Applications and Services)
- Business address
- Unit A 28 7, Tower A, Menara Uoa Bangsar, No. 5 Jln Bangsar Utama 1, Kuala Lumpur, 59000
- Incorporated in
- WY
- Fiscal year end
- 31 December
- Former names on EDGAR
- BioNexus Gene Lab Coporation (to 08 May 2020)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields